Michael K. Badman, et.al., Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis., Endocrinology, 2009, 150

http://rdf.ncbi.nlm.nih.gov/pubmed/19819944

Michael K. Badman, et.al., Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis., Endocrinology, 2009, 150

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Fgf21<tm1Emf>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4436716

class

http://purl.org/net/cito/citesAsAuthority

• Fgf21<tm1Emf>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4436716

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased brown adipose tissue amount_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0000005B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• hepatic steatosis_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0002628B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• abnormal body weight_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0001259B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• increased gonadal fat pad weight_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0009285B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• increased circulating cholesterol level_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0005178B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• abnormal brown fat cell morphology_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0009116B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• increased body weight_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0001260B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• increased circulating triglyceride level_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0001552B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• increased white fat cell size_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0009118B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• abnormal liver physiology_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0000609B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• impaired glucose tolerance_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0005293B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• abnormal glucose homeostasis_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0002078B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• impaired lipolysis_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0008033B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• abnormal food intake_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0005449B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• decreased oxygen consumption_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0005290B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• increased circulating leptin level_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0005669B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• increased liver weight_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0002981B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• increased lean body mass_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0003960B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• abnormal lipid level_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0001547B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• abnormal blood homeostasis_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0009642B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• increased liver triglyceride level_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0009355B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• increased circulating glucose level_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0005559B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• increased total body fat amount_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0010024B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• increased liver glycogen level_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0010400B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• abnormal lipid homeostasis_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0002118B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• abnormal hypothalamus secretion_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0001752B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• increased circulating insulin level_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0002079B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• abnormal adipose tissue morphology_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0000003B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• hypoactivity_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0001402B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf
• decreased fatty acid level_Fgf21<tm1Emf>/Fgf21<tm1Emf>
  http://metadb.riken.jp/0005282B6CgFgf21tm1EmfFgf21tm1EmfFgf21tm1EmfFgf21tm1Emf